Observations on the use of fulvic acid as a blood coagulant
In hospital studies, profuse otherwise unstoppable bleeding of the mucousmembranes of the nose, mouth, throat, bronchial and lung areas, related to acuterespiratory and viral infections in patients with tuberculosis, heart failure, leukemia, and other serious diseases, were successfully stopped with fulvic acid therapy. Suchen Cao, Jiangxi Humic Acid, 3 (1993)
Hospital patients with acute upper gastroenterological bleeding had 95.6% success rate when treated with fulvic acid oral medicine and injections. Yuan, Shenyuan; Fulvic Acid, 4 1988; in Application of Fulvic acid and its derivatives in the fields of agriculture and medicine; First Edition: June 1993 Pharmaceutical companies in Da Tong, Shanxi, in Gongxian, Henan and in Kunming, Yunnan are manufacturing humic acid medicines which are approved by the Chinese Drug Administration. Because of their non-toxicity, the humic extract fulvic acid is approved for internal as well as external use.
Observations on the use of fulvic acid as a blood coagulant
Since February, 1979, Suchen Cao and associates, of the Medical University in Zhejiang Province, China, had begun using fulvic acid in treating bleeding diseases. Until August of that year they had treated 15 cases, all giving satisfactory results, although only a small number of patients were involved. Source of Fulvic Acid, Types of Reagents, Methods of Usage Source: Fulvic acid was extracted from humic peat in the hospital preparation room in the Shaoxing area.
Types of reagents: (a) Fulvic acid 0.2% injection solution, 5 ml per injection, used intravenously or intramuscularly. (b) Fulvic acid in powder form, taken orally. Methods of usage: (a) Cotton swabs dipped in 0.2% fulvic acid solution were placed at the bleeding area in the mucous membrane. 27 (b) For treating patient coughing blood or hematuria patients (blood in urine), twice a day 5 ml of 0.2% fulvic acid solution injected intramuscularly, or once a day 40 ml of 0.2% fulvic acid solution added to glucose solution injected intravenously. (c) Patients suffering from bleeding from mucous membrane, coughing blood or hematuria were given fulvic acid therapy when other treatments failed. Clinical Data Fifteen cases of bleeding and stoppage of bleeding: Six had mucous membrane bleeding problem (4 with different degrees of severity of nasal membrane bleeding triggered by chronic kidney infection, uremia, pulmonary cardiac disease, leukemia, and cirrhosis; one had festered surface of the tongue caused by a lymph tumor; one had aplastic anemia causing gum bleeding); three hematuria patients (one each of acute bladder infection or cardiac hepatitis or leukemia); six patients coughing up blood (4 caused by bronchiectasis, one caused by tuberculosis, one caused by heart failure).
Bleeding mucous membrane:
1. Nasal bleed caused by uremia, pulmonary cardiac disease, leukemia, and cirrhosis. Four cases studied. Treatment as described above required one hour for blood coagulating. Treatment result was apparent cure with no relapse.
2. Festered surface of tongue caused by lymph tumor, brain membrane, leukemia. One case studied. Treatment as described above required wet cotton swab layering-over 2 or 3 times. Treatment result was apparent cure with no relapse.
3. Bleeding gum caused by aplastic anemia. One case studied. Treatment as described above required one hour for blood coagulating. Treatment result was apparent cure with no relapse.
1. Acute bladder infection, one case studied. Treatment was as prescribed above. The following day no blood found in urine, routine urine testing negative. Treatment result was apparent cure with no relapse.
2. Leukemia, blood shot eye, and hematuria (red cell ++), one case studied. Treatment was as prescribed above. Patient was getting better by the following day with no blood found in urine, no blood shot eye. Patient had relapse. 3. Cirrhosis, one case studied. Treatment was as prescribed above. Patient was getting better, with blood coagulating by the 4 th day. Patient had relapse. Coughing blood: 1. Bronchiectasis, four cases studied. Treatment was as prescribed above. Three cases were getting better with blood coagulating by the 5 th day, with no relapse. In one of the four cases, treatment showed no effect. 28 2. Tuberculosis, one case studied. Treatment was as prescribed above. Patient was getting better, with blood coagulating by the 3 rd day. Patient had relapse.
3. Heart failure, one case studied. Treatment was as prescribed above. Apparent cure by the 3 rd day, with no relapse. Treatment Results Six patients suffering from mucous membrane bleeding all showed apparent positive results. Five of them received localized layering-over treatment once and one received the same treatment 2 ~ 3 times. No relapse was observed in any case. Two out of three hematuria patients were found with no blood in their urine the day after the treatment. The routine urine test was negative. The treatment was effective with one patient and no relapse was observed. The other two patients had relapses. The routine urine test showed that the presence of red cells (++++) was reduced to (++). Continuing treatment did not show apparent improvement. One out the six patients who coughed blood showed an apparent response to the treatment; one did not get better; the other four showed signs of improvement. Within 3 to 5 days treatment, five patients stopped coughing blood. One of them stopped coughing blood but later started again. Discussion and Summary From the above case study, it is clear that fulvic acid indeed can stop bleeding. Patients with more serious illness, for example, suffering from aplastic anemia, chronic kidney infection uremia, after receiving treatment, except for one, had their bleeding stopped to a certain degree.
Examples: In 4 cases of nasal bleeding the patients were initially treated with gauze containing Anluoxue and Vaseline and in one case of gum bleeding the patient after initially treated with gauze containing coagulate agent, Anluoxue, Zhixueming, vitamin K, did not show obvious results. However, following one treatment by layering a cotton swab dipped in fulvic acid solution over the bleeding area, bleeding stopped. For one of the three cases of hematuria patients (caused by acute bladder infection), following 1 day treatment by intravenous injection, there was no blood in the urine on the following day. Three out the four cases of bronchiectasis patients were obviously better. On the 5 th day the coughing of blood was gradually reduced, however, traces of blood were still found in the sputum. According to reports in the literature, the therapeutic feature of fulvic acid resembles Yunnan Baiyao. Experimental results indicated that 30 minutes following intravenous injection of dogs with 160 mg of fulvic acid, the dog thrombus elasticity diagram showed the reduction of the reaction time R and the coagulation time K. The blood clotting process was accelerated yielding advantageous blood coagulation. 29 When this medicine was taken orally, there were two incidents showing nausea and vomiting, a condition hard to bear. The remainder did not have any bad reaction. Although we have not collected numerous data of the usage of this medication, the initial results show it to has the ability to stop bleeding.
Suchen Cao, Jiangxi Humic Acid, 3 (1993) In: Application of Fulvic acid and its derivatives in the fields of agriculture and medicine; Chapter 35; First Edition: June 1993.